These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12099045)

  • 1. [NMR-based approach for drug discovery].
    Osawa M; Ikura M
    Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):948-54. PubMed ID: 12099045
    [No Abstract]   [Full Text] [Related]  

  • 2. NMR in drug discovery on membrane proteins.
    Wirmer-Bartoschek J; Bartoschek S
    Future Med Chem; 2012 May; 4(7):869-75. PubMed ID: 22571612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discovering high-affinity ligands for proteins: SAR by NMR].
    Kamisuki S; Uesugi M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1818-9. PubMed ID: 18051441
    [No Abstract]   [Full Text] [Related]  

  • 4. NMR in drug discovery.
    Pellecchia M; Sem DS; Wüthrich K
    Nat Rev Drug Discov; 2002 Mar; 1(3):211-9. PubMed ID: 12120505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using NMR for ligand discovery and optimization.
    Villar HO; Yan J; Hansen MR
    Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-guided fragment-based approach for the design of AAC(6')-Ib ligands.
    Lombès T; Bégis G; Maurice F; Turcaud S; Lecourt T; Dardel F; Micouin L
    Chembiochem; 2008 Jun; 9(9):1368-71. PubMed ID: 18464231
    [No Abstract]   [Full Text] [Related]  

  • 7. NMR fragment screening: tackling protein-protein interaction targets.
    Schade M; Oschkinat H
    Curr Opin Drug Discov Devel; 2005 May; 8(3):365-73. PubMed ID: 15892252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils.
    Middleton DA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):985-90. PubMed ID: 17956260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
    Becattini B; Pellecchia M
    Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How lipophilic cannabinergic ligands reach their receptor sites.
    Makriyannis A; Tian X; Guo J
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):210-8. PubMed ID: 16099405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the binding of propranolol enantiomers to alpha1-acid glycoprotein with ligand-detected NMR experiments.
    Becker BA; Larive CK
    J Phys Chem B; 2008 Oct; 112(43):13581-7. PubMed ID: 18839985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR fragment screening: Advantages and applications.
    Schade M
    IDrugs; 2006 Feb; 9(2):110-3. PubMed ID: 16523400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design.
    Tsao DH; Sutherland AG; Jennings LD; Li Y; Rush TS; Alvarez JC; Ding W; Dushin EG; Dushin RG; Haney SA; Kenny CH; Malakian AK; Nilakantan R; Mosyak L
    Bioorg Med Chem; 2006 Dec; 14(23):7953-61. PubMed ID: 16919463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bead-linked proteoliposomes: a reconstitution method for nmr analyses of membrane protein-ligand interactions.
    Yokogawa M; Takeuchi K; Shimada I
    J Am Chem Soc; 2005 Aug; 127(34):12021-7. PubMed ID: 16117542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structural basis of the K+ channel inhibition by pore-blocking toxins, revealed by NMR].
    Takeuchi K; Shimada I
    Tanpakushitsu Kakusan Koso; 2005 Aug; 50(10 Suppl):1297-302. PubMed ID: 16104598
    [No Abstract]   [Full Text] [Related]  

  • 19. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR-guided fragment-based approach for the design of tRNA(Lys3) ligands.
    Chung F; Tisné C; Lecourt T; Dardel F; Micouin L
    Angew Chem Int Ed Engl; 2007; 46(24):4489-91. PubMed ID: 17486554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.